FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317862772> ?p ?o ?g. }

• W4317862772 endingPage "737" @default.
• W4317862772 startingPage "737" @default.
• W4317862772 abstract "737 Background: There is no reliable biomarker to guide treatment for patient with borderline resectable pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant modified (m)FOLFIRINOX. We investigated the role of plasma circulating tumor DNA (ctDNA) sequencing to discover potential biomarkers for patients treated with neoadjuvant mFOLFIRINOX in our phase 2 clinical trial (ClinicalTrials.gov identifier: NCT02749136). Methods: Among 44 patients enrolled in the trial, patients with plasma ctDNA analysis performed at baseline or post-operative period were included in the analysis. Plasma cell-free DNA isolation and sequencing of ctDNA were performed using the Guardant 360 assay. Association of clinical outcomes with germline or somatic mutations of DNA damage repair (DDR) genes was analyzed. Somatic alterations other than DDR genes were also analyzed to find potential biomarkers of neoadjuvant mFOLFIRINOX. Progression free-survival (PFS) was defined as time from the initiation of mFOLFIRINOX to disease progression or any cause of death. Overall survival (OS) was defined as the time from the initiation of mFOLFIRINOX to any cause of death. Results: Among 44 patients, 28 patients had ctDNA sequencing data qualified for the analysis and were included in this study (15 patients with baseline data only, 3 patients with post-operative data only, and 10 patients with both baseline and post-operative data). Median age was 59 (range, 41-73) years and 15 patients (53.6%) were male. Among 25 patients with baseline plasma ctDNA data, 11 patients (44%) had somatic or germline alteration of DDR genes detected at baseline including ATM, BRCA1, BRCA2 and MLH1, and showed significantly better PFS than those without such DDR gene alterations (median 26.6 vs. 13.5 months, log-rank p = 0.004). Although there was a trend for better OS in patients with DDR gene alterations, this was not statistically significant (log-rank p = 0.29). The most observed baseline somatic alteration was TP53 (n = 7, 28%), followed by KRAS (n = 6, 24%). Patients with somatic KRAS mutation at baseline had significantly worse OS (median 8.5 months vs. not applicable, log-rank p = 0.003) than those without. Among 13 patients with post-operative plasma ctDNA data, 8 patients (61.5%) had detectable somatic alterations. Conclusions: Detection of germline or somatic mutations of DDR genes from plasma ctDNA at baseline was associated with better survival outcomes of patients with borderline resectable PDAC treated with neoadjuvant mFOLFIRINOX. Detection of DDR gene alterations from plasma ctDNA may have a potential role as biomarker for prognosis in patients with borderline resectable PDAC treated with mFOLFIRINOX." @default.
• W4317862772 created "2023-01-25" @default.
• W4317862772 creator A5027994231 @default.
• W4317862772 creator A5030834546 @default.
• W4317862772 creator A5044558998 @default.
• W4317862772 creator A5050625196 @default.
• W4317862772 creator A5051712104 @default.
• W4317862772 creator A5060912167 @default.
• W4317862772 creator A5090754319 @default.
• W4317862772 date "2023-02-01" @default.
• W4317862772 modified "2023-10-15" @default.
• W4317862772 title "Analysis of plasma circulating tumor DNA in borderline resectable pancreatic ductal adenocarcinoma treated with neoadjuvant modified FOLFIRINOX: Clinical relevance of DNA damage repair gene alterations." @default.
• W4317862772 doi "https://doi.org/10.1200/jco.2023.41.4_suppl.737" @default.
• W4317862772 hasPublicationYear "2023" @default.
• W4317862772 type Work @default.
• W4317862772 citedByCount "0" @default.
• W4317862772 crossrefType "journal-article" @default.
• W4317862772 hasAuthorship W4317862772A5027994231 @default.
• W4317862772 hasAuthorship W4317862772A5030834546 @default.
• W4317862772 hasAuthorship W4317862772A5044558998 @default.
• W4317862772 hasAuthorship W4317862772A5050625196 @default.
• W4317862772 hasAuthorship W4317862772A5051712104 @default.
• W4317862772 hasAuthorship W4317862772A5060912167 @default.
• W4317862772 hasAuthorship W4317862772A5090754319 @default.
• W4317862772 hasConcept C104317684 @default.
• W4317862772 hasConcept C121608353 @default.
• W4317862772 hasConcept C126322002 @default.
• W4317862772 hasConcept C134305767 @default.
• W4317862772 hasConcept C13514818 @default.
• W4317862772 hasConcept C143998085 @default.
• W4317862772 hasConcept C2777148230 @default.
• W4317862772 hasConcept C2780210213 @default.
• W4317862772 hasConcept C2780259306 @default.
• W4317862772 hasConcept C2781197716 @default.
• W4317862772 hasConcept C501734568 @default.
• W4317862772 hasConcept C526805850 @default.
• W4317862772 hasConcept C55493867 @default.
• W4317862772 hasConcept C71924100 @default.
• W4317862772 hasConcept C86803240 @default.
• W4317862772 hasConceptScore W4317862772C104317684 @default.
• W4317862772 hasConceptScore W4317862772C121608353 @default.
• W4317862772 hasConceptScore W4317862772C126322002 @default.
• W4317862772 hasConceptScore W4317862772C134305767 @default.
• W4317862772 hasConceptScore W4317862772C13514818 @default.
• W4317862772 hasConceptScore W4317862772C143998085 @default.
• W4317862772 hasConceptScore W4317862772C2777148230 @default.
• W4317862772 hasConceptScore W4317862772C2780210213 @default.
• W4317862772 hasConceptScore W4317862772C2780259306 @default.
• W4317862772 hasConceptScore W4317862772C2781197716 @default.
• W4317862772 hasConceptScore W4317862772C501734568 @default.
• W4317862772 hasConceptScore W4317862772C526805850 @default.
• W4317862772 hasConceptScore W4317862772C55493867 @default.
• W4317862772 hasConceptScore W4317862772C71924100 @default.
• W4317862772 hasConceptScore W4317862772C86803240 @default.
• W4317862772 hasIssue "4_suppl" @default.
• W4317862772 hasLocation W43178627721 @default.
• W4317862772 hasOpenAccess W4317862772 @default.
• W4317862772 hasPrimaryLocation W43178627721 @default.
• W4317862772 hasRelatedWork W2012954058 @default.
• W4317862772 hasRelatedWork W2122804063 @default.
• W4317862772 hasRelatedWork W2599910524 @default.
• W4317862772 hasRelatedWork W2910998150 @default.
• W4317862772 hasRelatedWork W2941837211 @default.
• W4317862772 hasRelatedWork W2966671351 @default.
• W4317862772 hasRelatedWork W3008650849 @default.
• W4317862772 hasRelatedWork W3046481916 @default.
• W4317862772 hasRelatedWork W3132071672 @default.
• W4317862772 hasRelatedWork W4229863258 @default.
• W4317862772 hasVolume "41" @default.
• W4317862772 isParatext "false" @default.
• W4317862772 isRetracted "false" @default.
• W4317862772 workType "article" @default.